Alessandra Bosch/LinkedIn
Jul 22, 2026, 09:29
Alessandra Bosch: Presenting the Latest Evidence in Pediatric Anticoagulation at ISTH 2026
Alessandra Bosch, Attending Physician at Zurich Children’s Hospital, Clinician Scientist at University of Zurich, shared on LinkedIn:
”What a HOT week at ISTH 2026 in Paris!
Grateful for the chance and honour to give a state-of-the-art talk on periprocedural anticoagulation management in children, and to present our poster on real-world rivaroxaban use in children to such an engaged community.
But beyond the science, ISTH is always about the people!
Reconnecting with long-time colleagues, and making new connections that will turn into future collaborations.
Thank you to everyone who stopped by to chat, ask questions, or just say hello.
On to the next one.”
Stay updated with Hemostasis Today.
-
Sep 18, 2026, 17:48Ronak H. Mistry: Updated ASH Guidelines Bring New Focus to Iron Deficiency
-
Sep 18, 2026, 17:32Hassan Kawtharany: New Ferritin Cutoffs for the Diagnosis of Iron Deficiency With or Without Anemia
-
Sep 18, 2026, 17:20Abhishek G P: GAVE as an Important Cause of Chronic Gastrointestinal Blood Loss
-
Sep 18, 2026, 17:08Irem Karaman Sebin: ASH 2026 Changes a Key Concept in Iron Deficiency
-
Sep 18, 2026, 16:51Adarsh Krishnan Sundara Rajan: Is VTE the Most Underdiagnosed Critical Threat in Modern Healthcare?
-
Sep 18, 2026, 16:19CRISPR and Hemophilia: The Next Frontier of In Vivo Gene Editing
-
Sep 18, 2026, 16:13Christian Irsara: PF4 Immunothrombosis Following Natural Adenovirus Infection
-
Sep 18, 2026, 16:10Leo NicolaiÖ‰ The Spleen Emerges as a Key Regulator of Thromboinflammation
-
Sep 18, 2026, 16:05Targeting Factor XI to Reduce Thrombosis Without Compromising Hemostasis – ISTH